Press Release For immediate publication
Medall announces appointment of Arjun Ananth as company’s new CEO
Chennai, December 2, 2019: Medall, among India’s fastest growing integrated diagnostic service providers and the fourth largest diagnostics player in the country, today announced the appointment of Arjun Ananth as its new Chief Executive Officer. Ananth takes over from Medall founder, Raju Venkataraman who has decided to retire to pursue other interests.
Speaking on his appointment, Arjun Ananth, CEO, Medall Diagnostics says, “Raju has expressed his desire to retire from active day to day operations. The board felt that since I have been serving on the board as representative of Peepul Capital and have a good understanding of the business, in the interest of continuity, it would be appropriate for me to take over as CEO of Medall. Raju will continue to be on the board as a non-executive chairman and continues to hold shares in the company.
Peepul capital continues to remain committed to growing Medall and remains excited about the opportunity. The company will continue to expand aggressively across all its businesses, with a relentless focus on customer delight, operational excellence and profitability. The company will be announcing a slew of exciting initiatives and growth plans for the year ahead soon”.
Armed with an MBA in Finance and International Business from New York’s Stern School of Business in addition to being a Chartered Accountant, Ananth brings to Medall over 20 years of rich experience in growing and scaling businesses, from his previous stints across varied industries such as finance, automotive, chemicals and sports
Medall is India’s fastest growing integrated Healthcare Diagnostics and the fourth largest Diagnostics player in India. With 7000 plus customer touch points in 9 states and 70+ districts, 24 NABL accredited labs and 108 ISO Certified Labs, Medall provides both radiology and pathology services under one roof. Medall has served over 10 million customers and performed over 30 million tests in 2018. With a strong focus on digitisation and deployment of state of the art technology, Medall is pioneering clinical and technological innovations in Diagnostics. To know more please log on to: https://www.medall.in/about/index.html
For media enquiries, please contact: Santosh: PRHUB / +91-78927-72953 / email@example.com